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INTRODUCTION
Receptor tyrosine kinases are involved in many signalling
pathways in cell proliferation and differentiation. Activation of
these pathways depends on both the presence of the receptors
at the cell surface and on the availability of their ligands. Thus,
the extent of receptor activation can be regulated by the limited
production or by the restricted diffusion of their ligands (see
Jessell and Melton, 1992 for a review). The torso pathway in
Drosophila is a particularly appropriate model to address this
issue. The torso (Tor) receptor is distributed along all the
surface of the Drosophila embryo but it is only activated at the
poles, where it specifies development of terminal structures
(Schüpbach and Wieschaus, 1986a; Klinger et al., 1988;
Casanova and Struhl, 1989; Sprenger et al., 1989). Activation
of the Tor receptor has been shown to depend on a diffusible
extracellular ligand generated at each pole that is trapped by
the receptor, thereby impeding further diffusion (Sprenger and
Nüsslein-Volhard, 1992; Casanova and Struhl, 1993). 
However, it is still not known which is the terminal signal
and how it is generated. torso-like (tsl) and trunk (trk) are two
genes that are normally required for activation of the Tor
receptor and have been implicated in the local production or
action of the Tor ligand (Casanova and Struhl, 1989; Stevens
et al., 1990). tsl expression is restricted to specialised follicle
cells at each end of the maturing oocyte (Savant-Bhonsale and
Montell, 1993; Martin et al., 1994) and its product appears to
be found at both embryonic poles after fertilisation (Martin et
al., 1994). Moreover, its restricted expression in these follicle
cells appears to be critical to generate the localised terminal
signal in the embryo because ectopic tsl expression during
oogenesis causes central portions of the early embryo to
develop terminal structures (Savant-Bhonsale and Montell,
1993; Martin et al., 1994; Furriols et al., 1998). By contrast,
trk is required in the female germline (Schüpbach and
Wieschaus, 1986b), its RNA is distributed uniformly in the
oocyte and codes for a protein with similarities to several types
of extracellular growth factors that is likely to be secreted and
cleaved (Casanova et al., 1995).
In addition, two other genes, fs(1)pole hole (fs(1)ph; also
known as female sterile(1) M3) and fs(1) Nasrat (fs(1)N), seem
also to be required for local activation of the Tor receptor
(Casanova and Struhl, 1989). These genes are special because
the majority of mutant alleles at both loci lead to a collapsed
egg phenotype probably due to abnormalities in the vitelline
membrane surrounding the oocyte and only a particular
hypomorphic mutation for each gene gives rise to a terminal
phenotype (Degelmann et al., 1990). Thus, it has been
proposed that these two genes may have a dual function; they
may serve to stabilise the vitelline membrane and they may
also be involved in retention or stabilisation of the tsl product
in the perivitelline space at the egg poles (Degelmann et al.,
1990). 
Two models have been suggested for the activation of the
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Regulated activation of receptor tyrosine kinases depends
on both the presence of the receptors at the cell surface and
on the availability of their ligands. In Drosophila, the torso
tyrosine kinase receptor is distributed along the surface of
the embryo but it is only activated at the poles by a
diffusible extracellular ligand generated at each pole that
is trapped by the receptor, thereby impeding further
diffusion. Although it is known that this signal depends on
the activity of several genes, such as torso-like and trunk, it
is still unclear how is generated. The identification of the
signal responsible for the torso receptor activation is an
essential step towards understanding the mechanism that
regulates the local restriction of torso signalling. Here we
report that a fragment containing the carboxy-terminal
108 amino acids of the trunk protein retains trunk activity
and is sufficient to activate torso signalling. We also show
that this fragment bypasses the requirements for the other
genes involved in the activation of the torso receptor. These
results suggest that a cleaved form of the trunk protein acts
as a signal for the torso receptor. We therefore propose that
the restricted activation of the torso receptor is defined by
the spatial control of the proteolytic processing of the trunk
protein.
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Tor receptor. In one model, Tsl itself would be the Tor ligand:
release of Tsl from its terminal location, perhaps in the vitelline
membrane, would activate the Tor receptor in the blastoderm
membrane at both poles of the embryo (Martin et al., 1994; see
Duffy and Perrimon, 1994 for a review). In another model, Trk
might be secreted intact into the perivitelline fluid layer and
locally activated by proteolytic cleavage to generate the ligand
for the Tor receptor (Casanova et al., 1995). This possibility
has been reinforced by the similarity between Trk and spätzle
(Spz), the putative ligand for the Toll receptor involved in
dorsoventral patterning (Morisato and Anderson, 1994;
Schneider et al., 1994). In the first model, restricted activation
of Tor signalling would be regulated by the localised deposition
of its ligand. In the alternative model, the local processing of
a uniformly distributed ligand precursor would regulate the
domain of activation of the Tor pathway.
The identification of the signal responsible for Tor receptor
activation is an essential step towards understanding the
mechanism that regulates the local restriction of Tor activation.
Here we report that a fragment containing the carboxy-terminal
108 amino acids of the Trk protein retains Trk activity and is
sufficient to activate Tor signalling. We also show that this
fragment bypasses the requirements for the other genes
involved in the activation of the Tor receptor. These results
suggest that a cleaved form of the Trk protein acts as a signal
for the Tor receptor. We therefore propose that the restricted
activation of the Tor receptor is defined by the spatial control
of the proteolytic processing of Trk.
MATERIALS AND METHODS
Fly strains
trkV67-1 is a mutation that results from the insertion of a P element and
behaves as a null allele (Casanova et al., 1995). torXR1 is a small
deficiency that deletes the tor gene (Sprenger et al., 1989). tsl604 is a
P element induced mutation (Martin et al., 1994). fs(1)ph1901 and
fs(1)N211 are EMS induced mutations in those genes displaying the
specific terminal phenotype (Degelmann et al., 1990). For the
ubiquitous early expression of trkC-108, we used the nos-GAL4-VP16
line (Van Doren et al., 1998).
Plasmid constructs
Full-length trk (pNB-R3)
To introduce the 5 ¢ UTR region of the b -globin gene in front of a full
trk cDNA we cloned a full trk cDNA from position 1987 to 2752 in
the genomic map (Casanova et al., 1995) into a pNB40 derivative
(Brown and Kafatos, 1988). To generate truncated forms of Trk that
would be appropriately secreted we decided to use well-defined
sequences that have already been proved to functionally work as
signal peptides, even in the context of heterologous proteins (see, for
example, Smith and DeLotto, 1994).
trkc-159
We first generated a pea-R3 plasmid by cloning the cDNA of easter
(ea) (Chasan and Anderson, 1989) in front of the trk cDNA. By
reverse PCR with primers GCCCGCCGATGATTTCGC and
TCGTCGTACGAGCTGCCC we generated a plasmid coding for the
ea signal peptide up to the glycine residue at position 20 fused to the
serine residue of trk at position 68.
trkc-108
By reverse PCR from pea-R3 with primers GCCCGCCGATGA-
TTTCGC and GTGGGACATCCGAGAATC we generated a plasmid
coding for the ea signal peptide up to the glycine residue at position
20 fused to the valine residue of trk at position 119. 
trkc-100
We first generated a pwg-R3 plasmid by substituting a trk cDNA
fragment from 2025 to 2088 in the genomic map (Casanova et al.,
1995) by a 93 bp EcoRV-BssHI fragment from wingless (wg) that
includes the sequence for its signal peptide (Rijsewijk et al., 1987).
By reverse PCR with primers GCCGCTGCACAGGGCCAT and
TTTCCACGCTATATCCGTTC we generated a plasmid coding for
the wg signal peptide up to the glycine residue at position 17 fused to
the phenylalanine residue of trk at position 148.
pUAST-trkC-108
The complete coding sequence from the plasmid trkC-108 was excised
as an EcoRI-XhoI fragment, cloned in a vector with two NotI flanking
sites and inserted as a NotI fragment into the pUAST vector (Brand
and Perrimon, 1993). By P-element mediated transformation we
generated several independent fly strains carrying the UAS-trkC-108
construct. 
RNA injections
RNA was synthesised from trkC-100, trkC-108 and trkC-159 plasmids
using the mMessage mMachine kit (Ambion) according to the
manufacturer’s instructions. The RNA was injected at a concentration
between 1.5 and 2.5 ng/nl in the posterior pole of 0- to 45-minute-old
embryos layed by homozygous mutant females at 17°C. The embryos
were developed for 4 days at 17°C and the cuticles were fixed
according the standard procedures. Rescue was scored by the presence
of the filzkörper.
In situ hybridisation
tll and hkb probes were generated from cDNA clones provided by
J. Lengyel and H. Jäckle, respectively. Whole-mount in situ
hybridisation were done following the method of Tautz and Pfeifle
(Tautz and Pfeifle, 1989) with minor modifications.
RESULTS
Putative cleavage sites in the Trk protein 
The molecular characterisation of the trk gene has shown that
it encodes a protein with analogies to extracellular ligands and
likely to be cleaved. More precisely, the Trk protein resembles
Spz, the putative ligand for the Toll receptor. The analysis of
the trk sequence has revealed a putative cleavage site at
position 67 in the predicted protein that would generate a
carboxy-terminal fragment of 159 amino acids (trkC-159). In
addition, the conserved arginine immediately upstream of this
putative cleavage site is changed to a glutamine in the trk6 loss-
of-function mutation (Casanova et al., 1995). The observation
that a mutation in a putative cleavage site eliminates the
biological function of the Trk protein suggests that cleavage is
an essential step for Trk activity. 
Further analysis of the trk sequence has unveiled an
additional putative cleavage site at position 119, which would
give rise to a carboxy-terminal fragment of 108 amino acids
(trkC-108). Several reasons suggested that this additional site
could also be important for Trk activity. First, Trk shares some
sequence similarity with the prothoracicotropic hormone
(PTTH) of Bombyx mori (data not shown), which is presumed
to be cleaved at different sites to yield a final carboxy-terminal
fragment of 109 amino acids (Kawakami et al., 1990). Second,
Spz is cleaved at a similar position between Arg220 and Val221
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to yield an active fragment of 106 amino acids (Morisato et al.,
1994, DeLotto and DeLotto, 1998). The cleavage site of Spz,
VSSRVGGS, bears some similarity to the putative cleavage
site of Trk, FHDRVGHP (Fig. 1A). And third, most of the
active forms of the growth factors with a cystine knot motif
possess only a small fragment amino terminal to the first
cysteine of the knot (for a review, see McDonald and
Hendrickson, 1993). In this regard, the Trk carboxy-terminal
fragment generated by cleavage at position 119 (trkC-108) fits
this 'rule' better than the fragment generated by cleavage at
position 67 (trkC-159). 
The analysis of the trk sequence, the presence of putative
cleavage sites and the mutation on a cleavage site that abolishes
trk function prompted us to study the biological activity of
deleted forms of the trk gene.
The C-terminal fragment of the Trk protein retains
Trk activity 
We have constructed a series of deletions of the trk gene to
generate Trk proteins that would lack different amino-terminal
fragments while retaining a signal peptide to direct these
deleted proteins to the perivitelline space. To generate
truncated forms of Trk that would be appropriately secreted we
decided to use sequences that had already been characterised
as well-defined signal peptides. To assess the activity of these
truncated forms, we injected the different transcripts at the
posterior pole of embryos laid by trk mutant females. First, as
a control, we have verified that trk full-length transcripts were
able to rescue the phenotype of embryos from trk mutant
females (35% of rescued embryos; n=72); we did not detect
any rescue when these transcripts were injected in embryos
from tsl mutant females (data not shown).
In particular, we have generated two deleted forms that
mimic the result of cleavage events at the putative sites in
positions 67 and 119. These two forms, TrkC-159 and TrkC-108,
retain the 159 and the 108 carboxy-terminal residues
respectively. We have also generated a third deleted form that
retains only the last 100 amino acids, TrkC-100 (Fig. 1B).
Although injection of these truncated transcripts was not very
effective, we have found that TrkC-159 and TrkC-108 retained
trk activity as they were able to partially rescue the trk mutant
phenotype as indicated by the appearance of filzkörpers,
structures that are never present in trk mutant embryos (Fig.
2 and Table 1). The low percentage of rescued embryos
obtained with these modified trascripts compared to the full-
length transcript probably reflects the low stability of the
truncated mRNAs and/or proteins. Conversely, we could not
detect any Trk activity associated with the TrkC-100 fragment.
Thus, we conclude that a truncated Trk protein that contains
at least its 108 carboxy-terminal amino acids retains Trk
activity.
The C-terminal fragment of Trk bypasses the
requirement for the other genes acting in Tor
receptor activation
The ability of TrkC-108 to induce terminal structures suggested
that a carboxy-terminal fragment of the Trk protein could
function as an active signal for the Tor receptor once cleaved
from its amino-terminus. This raised the possibility that
the other genes required for normal activation of the Tor
receptor would be involved in the local processing of the Trk
protein at the embryonic poles. Consistent with this
hypothesis, injections of trkC-108 RNA were also able to
induce terminal structures in embryos mutant for tsl, fs(1)N
and fs(1)ph (Fig. 2). These experiments indicate that TrkC-108
bypasses the requirement for these three genes and places trk
downstream of tsl, fs(1)N and fs(1)ph in the genetic pathway
that controls Tor activation. As expected if TrkC-108 were
activating the Tor receptor, no rescuing activity was observed
upon injection in embryos laid by tor mutant females (Fig.
2).
As mentioned above and like trkC-108, trkC-159 can also
induce terminal structures when injected into trk mutant
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Fig. 1. Generation of deletions in the trk coding region.
(A) Schematic representation of the Spz cleavage and the Trk
putative cleavage site at position 119. (B) Schematic representation
of the different truncated forms of Trk, TrkC-159, TrkC-108 and
TrkC-100. The light grey box represents the N-terminal signal
sequence, from ea in the case of TrkC-159and TrkC-108 and from wg in
TrkC-100. Each C denotes a cysteine residue. 
Table 1. Induction of terminal structures by trkC-108 and
trkC-159 RNA injection
RNA injected Maternal genotype Embryos scored Fz(%)
trkC-108 trkV67-1 149 2
tsl604 83 9.6
fs(1)N211 309 3.2
fs(1)ph1901 82 2.4
torXR1 267 0
trkC-159 trkV67-1 88 1.1
tsl604 118 4.3
fs(1)N211 221 7.7
fs(1)ph1901 380 1.3
RNA transcripts were injected at the posterior pole of the embryos.
Embryos were scored for the differentiation of filzkörper structures (Fz)
which are not present in the absence of Tor signalling.
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embryos. We therefore addressed the question of whether this
larger fragment would behave similarly to the full-length Trk
protein and still require the activity of the genes upstream of
trk in the genetic pathway. Thus, we assayed the trkC-159 RNA
in embryos mutant for tsl, fs(1)N and fs(1)ph and we found that
it can also induce terminal structures in these mutant
backgrounds (Table 1). We therefore conclude that activity
of TrkC-159 does not depend on any of these genes. Since
TrkC-108 holds the same activity as TrkC-159, it is possible that
TrkC-159 could represent an intermediate in the generation of
an active form of Trk (see Discussion). 
The C-terminal fragment of Trk can induce tll and
hkb expression
The activity of the deleted forms of the trk gene upon mRNA
injection was assessed by the appearance of filzkörpers in the
cuticle of the developed embryos. In this assay, few embryos
could be scored as positive. As mentioned above, the
efficiency of the injections was very poor probably due to the
low stability of the truncated mRNAs and/or proteins. Thus,
it was crucial to analyse whether the C-terminal fragment of
Trk could trigger all the downstream responses of the Tor
signalling pathway. The zygotic genes tailless (tll) and
huckebein (hkb) appear to be the only targets of Tor activation
at the posterior pole of the embryo (Weigel et al., 1990). More
precisely, only high levels of Tor signalling appear to be
able to activate hkb expression (Furriols et al., 1996). Thus,
to further characterise the activity of the C-terminal fragment
of the Trk protein we have examined whether it could
induce tll and hkb expression in mutant embryos for tsl. To
overcome the difficulties of the RNA injection assay, we have
generated transgenic lines expressing TrkC-108 under the
control of the UAS promoter (Brand and Perrimon, 1993). We
used these lines to obtain ubiquitous expression of TrkC-108
at early embryonic stages by means of a maternal GAL4 line
(see Materials and Methods). These conditions were
sufficient to provide full terminal activity as they could
induce both tll and hkb expression in embryos mutant for tsl
(Fig. 3).
The C-terminal fragment of Trk can induce
phenotypes associated with general activation of
the Tor receptor
The above experiments indicate that a general level of TrkC-108
can generate restricted expression of the target genes of the Tor
signalling at both poles of the embryo. Similar results are
observed when Tor signalling is activated at low levels all over
the embryo, either by general expression of tsl (Furriols et al.,
1998) or by a constitutive ligand-independent mutation in the
Tor receptor (Steingrímsson et al., 1991). Only when higher
levels of Tor signalling are achieved it is possible to detect its
deleterious effect in the central regions of the embryo.
Consistently, we have observed that some embryos derived
from females bearing three copies of the UAS-trkC-108 and a
maternal GAL4 insertion (see Materials and Methods) have
deletions of the middle body segments (Fig. 4). This is the
phenotype associated with the expansion of the terminal
portions of the embryo at the expense of the central region
(Klinger et al., 1988), a phenotype that is more sensitive to
weak general activation of the Tor receptor than in situ analysis
for tll and hkb expression (see for example, Cleghon et al.,
1996 and Furriols et al., 1998). This result suggests that the
C108 carboxy-terminal fragment of Trk is sufficient to induce
terminal fates all over the embryo. 
DISCUSSION
A C-terminal fragment of Trk can act as a signal for
the Tor receptor 
The molecular characterisation of the trk gene suggested that
it could encode the ligand for the Tor receptor. In particular,
this possibility was sustained by the finding that the Trk protein
might be secreted and cleaved to yield a carboxy-terminal
polypeptide. This carboxy-terminal fragment displays an
arrangement of cysteines reminiscent of that of the cystine knot
motif present in several growth factors. Specifically, the
similarities between Trk and Spz, which is thought to be the
ligand for the Toll receptor in the establishment of the
A. Casali and J. Casanova
Fig. 2. trkC-108 retains Trk activity and
bypasses the requirement for the other
genes acting in Tor receptor activation.
(A) Wild-type embryo. (B) Embryo
from a trkV67-1 female. Observe that the
structures posterior to the seventh
abdominal segment are absent. (C-
F) Embryos from trkV67-1 (C), tsl604
(D), fs(1)N211 (D) and torXR1
(F) females injected at the posterior
pole with trkC-108 RNA. Note the
presence of filzkörpers (arrows) in
injected embryos from trk, tsl and
fs(1)N mutant females, but not in
injected embryos from tor mutant
females.
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Drosophila dorsoventral axis, raised the possibility that Spz
and Trk could function in an analogous fashion (Casanova et
al., 1995). However, this notion was not in agreement with
previous studies that indicated that the properties of Tsl protein
were consistent with its role as the Tor ligand (Martin et al.,
1994). Therefore, the nature of the Tor ligand, and hence the
mechanism of Tor activation, has remained unresolved. The
results reported here clearly substantiate that a C-terminal
fragment of the Trk protein can act as a signal for the Tor
receptor. Although the injection of the truncated versions of
the trk RNA is rather inefficient in terms of the percentage of
rescued embryos, our results indicate that a C-terminal
fragment of Trk is sufficient to trigger all the known responses
of the Tor signalling pathway. In particular, the C-terminal
fragment of Trk is able to induce these responses in the absence
of the function of the other genes required for Tor receptor
activation, including tsl. Besides, general expression of a C-
terminal fragment of Trk is sufficient to produce similar
phenotypes to those associated with the ubiquitous activation
of the Tor receptor. These results single out the product of the
trk gene as the only one sufficient and absolutely required for
the activation of the Tor receptor, even though other gene
functions could collaborate in the process. 
The C-terminal domain of Trk is sufficient to activate the
Tor receptor but its activity appears to be inhibited by the
presence of the amino-terminal domain of the protein.
Although the deletion mutations that we have generated may
not represent the actual in vivo protein, we favour the
hypothesis that the truncated proteins could mimic the in vivo
active protein and relieve the C-terminal region from such an
inhibition. In particular, the observation that a mutation in a
putative cleavage site eliminates the biological function of the
Trk protein (Casanova et al., 1995) suggests that cleavage is
physiologically relevant for Trk activity and weakens the
possibility that the designed truncated forms would artificially
alter the normal process of Trk protein activation. 
A two step processing of the Trk protein?
The analysis of trk has unveiled the existence of two putative
cleavage sites. Indeed, we have found that two different
deletions generated at each site that retain 159 and 108 amino
acids respectively are both able to activate Tor signalling in the
embryos upon RNA injection. Although we have already
mentioned that these two mutant forms may not represent the
actual in vivo active protein, we favour the hypothesis that the
smaller fragment could be similar to the in vivo active Trk
fragment whereas the larger one could correspond to an
intermediate form. In that case, the in vivo processing of the
Trk protein could involve more that one cleavage event. Several
observations support this model. Firstly, TrkC-108 is sufficient
to activate Tor signalling as indicated by the expression of both
tll and hkb, suggesting that the additional amino acids in
TrkC-158 are dispensable for Tor activation. In addition,
TrkC-108 fits very well with the other known active cystine-knot
factors, both in its overall size and in the small amino acid
chain just before the first cysteine of the knot (see McDonald
and Hendrickson, 1993). Finally, as discussed above, the
putative cleavage site at the basis of TrkC-158 appears to be
functionally important as a specific mutation at this site renders
the protein inactive (Casanova et al., 1995). Thus, both
cleavage events could be taking place in the in vivo processing
of Trk. A similar situation has been described for another
putative cystine-knot protein, the PTTH hormone of Bombyx
Fig. 3. TrkC-108 can induce tll and hkb expression.
(A-B) In wild-type embryos, tll (A) and hkb
(B) expression is restricted to the poles. (C-D) In
embryos from tsl604 females, tll (C) and hkb
(D) expression is missing at the posterior pole;
expression remains in the anterior domain due to the
activity of the anterior system. (E-F) Uniform
expression of trkC-108 by a nos-GAL4-VP16 driver
restores the ability of the terminal system to direct
the expression of tll (E) and hkb (F) at the poles of
embryos from tsl604 females.
Fig. 4. trkC-108 can induce deletions of the middle segments of the
embryo. Cuticle phenotype of an embryo expressing a large amount
of trkC-108 (derived from a female bearing 3 copies of the UAS-
trkC-108 and a nos-GAL4-VP16 insertion). Observe the deletion of
the middle embryonic segments, a phenotype typically associated
with ectopic activation of the Tor receptor.
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mori (Kawakami et al., 1990), which bears some sequence
similarity to Trk (data not shown). Likewise, the Trk active
form could arise from the cleavage at position 119 that would
require a previous cleavage at position 67. It has to be noted
that in this model the cleavage at position 67 could be the target
of the locally restricted processing at the embryonic poles since
TrkC-158 can already bypass the requirement for the other genes
needed for local activation of the Tor receptor. Conversely,
cleavage at position 119 would not need to be locally
controlled.
The spatial control of Tor receptor activation 
The Tor receptor is distributed all along the embryonic surface
but it is only activated at the poles by a still unknown
mechanism. Two models have been proposed for the locally
restricted activation of the Tor receptor. In one model, the Tsl
protein that is secreted from a subset of follicular cells at both
poles of the oocyte would act as a ligand for the Tor receptor
(Martin et al., 1994). In such a scenario, the spatial restriction
in the activation of the Tor receptor would lie in the local
production of its ligand. In an alternative model, Trk would be
secreted into the perivitelline fluid layer and then activated at
the embryonic poles by a proteolytic cleavage to generate the
ligand for the Tor receptor (Casanova et al., 1995). In this
alternative model, based on the characteristics of the Trk
protein, the spatial restriction in the activation of the Tor
receptor would lie in the local processing of its ligand. Our
experiments clearly support this second model and suggest that
the other genes required for Tor activation are involved in the
local generation of a Trk active form.
The molecular characterisation of the trk gene unveiled the
similarities between Trk and Spz, the presumed ligand for the
Toll receptor. The present experiments extend the similarity
between the terminal and the dorsoventral system as they
indicate that in both systems a transmembrane receptor is
activated by a ubiquitous ligand that is asymmetrically cleaved
into an active form. However, while a well characterised
cascade of serine proteases has been identified in the
dorsoventral system (Chasan and Anderson, 1989; DeLotto and
Spierer, 1986; Hong and Hashimoto, 1995, Konrad et al., 1998),
there are no known genes coding for proteases in the terminal
system. Since the terminal genes fs(1)ph and fs(1)N have not
yet been molecularly characterised it is possible that one of
them could code for a protease. In this context it is interesting
to note that nudel (ndl), one of the genes coding for a protease
in the dorsoventral system, is also needed for vitelline
membrane integrity (Hong and Hashimoto, 1995), a function
that is also shared by both fs(1)ph and fs(1)N (Degelmann et al.,
1990). Still, it is also possible that additional genes required for
Tor receptor activation remain to be identified. 
A critical step in both systems is the mechanism that triggers
the production of the active form of the ligand. In the
dorsoventral system this mechanism is initiated by the
restricted expression of pipe in the ventral follicle cells. pipe
codes for heparan sulfate 2-O-sulfotransferase that modifies
the glycosaminoglycan (GAG) side chain of proteoglycans
(Sen et al., 1998). Modification of Ndl, or of a yet unknown
substrate, by pipe would in turn allow the nucleation of a
protein complex that would begin the proteolytic cascade
leading to the production of active Spz. Much less is known
about this mechanism in the terminal system, which is also
initiated by the restricted expression of a particular gene in a
subset of follicle cells. In this case, tsl expression in some
follicle cells at each end of the maturing oocyte defines the
restricted domain of Tor activation (Savant-Bhonsale and
Montell, 1993; Martin et al., 1994). However, it is not clear
how tsl activity is translated into the production of an active
form of the Tor ligand. The only specific characteristic of the
Tsl protein is the presence of leucine-rich repeats which could
mediate protein-protein or protein-lipid interactions (Savant-
Bhonsale and Montell, 1993). Thus, it is possible that the Tsl
product could constitute the link binding a processing complex
to the membrane, but other alternative mechanisms are also
possible. The understanding of the mechanism that translates
the original asymmetry in the follicle cells to the restricted
production of active Trk will require the characterisation of the
additional genes needed for Trk processing and thus for Tor
activation.
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